Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GMDAQ

Gamida Cell (GMDAQ) Stock Price, News & Analysis

About Gamida Cell Stock (NASDAQ:GMDAQ)

Advanced Chart

Key Stats

Today's Range
$0.0160
$0.0183
50-Day Range
$0.0170
$0.0170
52-Week Range
$0.01
$2.51
Volume
332,754 shs
Average Volume
6.58 million shs
Market Capitalization
$2.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Gamida Cell Ltd. is a biopharmaceutical company. It focuses on developing cell therapies to cure cancer and rare and serious hematologic diseases. The company's product pipeline consists of NiCord and NAM-NK which are in clinical stage. It operates primarily in the United States, the European Union and internationally. Gamida Cell Ltd. is headquartered in Jerusalem, Israel.

Receive GMDAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gamida Cell and its competitors with MarketBeat's FREE daily newsletter.

GMDAQ Stock News Headlines

Gamida Cell Ltd. (GMDAQ)
Trump Treasure April 19
Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…
GMDAQ Gamida Cell Ltd.
Gamida Cell Ltd.
See More Headlines

Company Calendar

Today
4/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:GMDAQ
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-63,000,000.00
Pretax Margin
-2,317.95%

Debt

Sales & Book Value

Annual Sales
$1.78 million
Price / Cash Flow
N/A
Book Value
($0.02) per share
Price / Book
-0.85

Miscellaneous

Free Float
143,699,000
Market Cap
$2.62 million
Optionable
Optionable
Beta
1.30

This page (NASDAQ:GMDAQ) was last updated on 4/27/2025 by MarketBeat.com Staff
From Our Partners